期刊文献+

单中心162例血管性血友病患者的临床分析 被引量:3

Clinical studies of 162 patients with von Willebrand disease
原文传递
导出
摘要 目的总结国内单中心血管性血友病(VWD)的临床特征和诊治现状。方法回顾性分析162例VWD患者的临床资料和实验室检查结果。结果162例患者中男76例[中位年龄7.2(2.0-41.0)岁]、女86例[中位年龄20.7(5.0-48.0)岁]。1型VWD患者86例(53.1%),2型42例(25.9%,其中2A型33例、2M型4例、2N型5例),3型34例(21.0%)。87例(53.7%)患者有明确出血性疾病家族史。出血表现以皮肤瘀斑(61.7%)、鼻出血(53.7%)、手术或外伤后出血不止(53.1%)为主,月经量多为女性患者常见主诉(66.3%)。56例(34.6%)患者Vieenza出血评分为异常出血。45例(27.8%)患者接受血制品替代治疗,8例患者接受1.去氨基.8.右旋.精氨酸血管加压素治疗。57例月经量多的女性患者中,8例联合孕激素控制出血,2例行子宫切除术。结论VWD临床表现异质性较高,应分步进行确诊及分型检查并实施个体化治疗。 Objective To analyse the epidemiological feature, clinical characters and therapeutic regimens for von Willebrand disease (VWD). Methods The clinical data and laboratory tests results of 162 VWD patients in our center were analyzed. Results There were 76 males and 86 female among these patients with the mean age of 7.2 (2.0-41.0) and 20.7 (5.0-48.0) years, respectively. 86 patients (53.1%) were identified to be type 1 VWD, 34 patients (21.0%) type 3 VWD and 42 patients (25.9%) type 2 VWD. Among type 2 VWD patients, 33 patients were type 2A, 4 patients type 2M, 5 patients type 2B. Eighty-seven patients (53.7%) had a definite family history of bleeding tendency. The most common and specific bleeding symptoms were easy bruising (61.7%), epistaxis (53.7%), prolonged bleeding after surgery or minor injury (53.1%). Menorrhagia (66.3%) was common in female patients. The analysis of Vicenza bleeding scores in all patients showed that only 56 (34.6%) patients had abnormal bleeding scores. FVIII/VWF concentrates and cryoprecipitate were applied to 45 patients (27.8%), Desmopressin (DDAVP) to 8 patients. Eight female patients need oral contraceptives jointly to control menorrhagia. Hysterectomy had to be performed in 2 female patients with VWD. Conclusion VWD was a common congenital bleeding disorder with heterogeneous characters, it was necessary to screen, identify, classify accurately this disease in order to supply to effectively individulized treatment.
出处 《中华血液学杂志》 CAS CSCD 北大核心 2014年第2期152-156,共5页 Chinese Journal of Hematology
关键词 血管性血友病 血管性血友病因子 临床研究 von Willebrand diseases von Willebrand factor clinical studies
  • 相关文献

参考文献16

  • 1无,阮长耿,余自强.血管性血友病诊断与治疗中国专家共识(2012年版)[J].中华血液学杂志,2012,33(11):980-981. 被引量:19
  • 2Rodeghiero F,Castaman G,Dini E. Epidemiological investigation of the prevalence of von Willebrand' s disease[J].{H}Blood,1987,(2):454-459.
  • 3Sadler JE,Budde U,Eikenboom JC. Update on the pathophysiology and classification of von Willebrand disease:a report of the Subcommittee on von Willebrand Factor[J].{H}Journal of Thrombosis and Haemostasis,2006,(10):2103-2114.
  • 4Rodeghiero F,Castaman G,Tosetto A. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease:an international,multicenter study[J].{H}Journal of Thrombosis and Haemostasis,2005,(12):2619-2626.
  • 5National Institutes of Health. The diagnosis,evaluation and management of von Willebrand disease[M].Bethesda (MD):NIH Publication,2007.26-30.
  • 6Zhao Y,Gu Y,Ji S. Development of an ELISA method for testing VWF ristocetin cofactor activity with improved sensitivity and reliability in the diagnosis of von Willebrand disease[J].{H}European Journal of haematology,2012,(5):439-445.
  • 7王迎春,施文瑜,张威,邵波静,白霞,陆德炎,阮长耿.胶原结合试验在血管性血友病诊断和分型中的应用[J].中华血液学杂志,2003,24(9):491-492. 被引量:2
  • 8张敬宇,王迎春,张威,阮长耿.ELISA法vWF-FⅧ结合试验的建立及其临床应用[J].中华血液学杂志,2000,21(2):105-106. 被引量:1
  • 9Bowman M,Hopman WM,Rapson D. A prospective evaluation of the prevalence of symptomatic von Willebrand disease (VWD) in a pediatric primary care population[J].{H}PEDIATRIC BLOOD & CANCER,2010,(1):171-173.
  • 10Xu J,Yu Z,Zhang L. Diagnosis and management of von Willebrand disease in China[J].{H}Seminars in Thrombosis and Hemostasis,2011,(5):607-614.

二级参考文献29

  • 1郑炳旭,魏晓林,陈庆寿.钢筋混凝土高烟囱爆破切口支撑部破坏观测研究[J].岩石力学与工程学报,2006,25(z2):3513-3517. 被引量:23
  • 2齐世福,阎家良.高耸建筑物定向爆破倾倒时的后座及其对策[J].爆炸与冲击,1989,9(4):318-327. 被引量:18
  • 3奚晓东 阮长耿 等.抗血管性假血友病因子单克隆抗体ELISA的建立及其临床应用[J].中华医学检验杂志,1988,11(5):272-272.
  • 4邓家栋 杨崇礼 杨天楹等主编.临床血液学. 第1版[M].上海: 上海科学技术出版社,2001.1385-1393.
  • 5Sadler JE, Grainnick HR. A new classfication for von Willebrand disease.Blood, 1994,84:676.
  • 6Federici AB,Elder JH,De Marco L,et al.Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation[J].J Clin Invest.1984,74:2049~2055.
  • 7Matsui T,Fujimura Y,Nishida S.et al.Human plasma alpha2-macroglobulin and von Willebrand factor possess covalently linked ABO(H)blood group antigens in subjects with corresponding ABO phenotype[J].Blood,1993,82:663~668.
  • 8Matsui T,Titani K,Mizuochi T Structures of the Asparagine-linked oligosaccharide chains of human yon Willebrand factor:occurrence of blood group A,B and H(O)structures[J].Journal of Biological Chemistry,1992,267:8723~8729.
  • 9Sodetz JM,Pizzo SV,McKee PA.Relationship of sialic acid to function and in vivo survival of human factorⅧ/von Willebrand factor protein[J].J Biol Chem,1977,252:5538.
  • 10Haley E,Babar N,Ritter C,et al.Effect of ABO blood group on the collagen-binding assay for von Willebrand factor[J].Am J Haematol,2002,71:229~231.

共引文献25

同被引文献14

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部